Abstract

The global pharmaceutical market has undergone significant transformations between 2020 and 2025, driven by advancements in biotechnology, regulatory changes, and the aftermath of the COVID-19 pandemic. This study examines emerging trends, including the rise of personalized medicine, digital therapeutics, biosimilars, and artificial intelligence (AI) in drug discovery. A comparative analysis was conducted using market reports, clinical trial data, and industry forecasts to evaluate growth patterns across key regions (North America, Europe, Asia-Pacific, and Rest of the World). Findings indicate a shift toward value-based healthcare, increased R&D investments in rare diseases, and the growing influence of emerging markets. The study highlights challenges such as pricing pressures, supply chain disruptions, and regulatory hurdles while projecting future opportunities for innovation.